The present study confirmed that the lncRNA XIST is upregulated in clinical NSCLC samples, and its expression is further enhanced in cisplatin-resistant tumors and in human NSCLC cells treated with cisplatin (DDP). The gene discussed is XIST; the disease is non-small cell lung carcinoma.